Does APIXABAN Cause Pulmonary embolism? 2,714 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 2,714 reports of Pulmonary embolism have been filed in association with APIXABAN (ELIQUIS). This represents 1.7% of all adverse event reports for APIXABAN.
2,714
Reports of Pulmonary embolism with APIXABAN
1.7%
of all APIXABAN reports
252
Deaths
1,261
Hospitalizations
How Dangerous Is Pulmonary embolism From APIXABAN?
Of the 2,714 reports, 252 (9.3%) resulted in death, 1,261 (46.5%) required hospitalization, and 333 (12.3%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APIXABAN. However, 2,714 reports have been filed with the FAERS database.
What Other Side Effects Does APIXABAN Cause?
Death (18,501)
Cerebrovascular accident (7,237)
Atrial fibrillation (5,690)
Off label use (5,590)
Thrombosis (5,298)
Fall (5,063)
Cardiac disorder (4,917)
Haemorrhage (4,770)
Dyspnoea (4,379)
Gastrointestinal haemorrhage (4,030)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
DROSPIRENONE\ETHINYL ESTRADIOL (1,295)
Which APIXABAN Alternatives Have Lower Pulmonary embolism Risk?
APIXABAN vs APOMORPHINE
APIXABAN vs APRACLONIDINE
APIXABAN vs APREMILAST
APIXABAN vs APREPITANT
APIXABAN vs APROTININ